MAS maintained the cattle tick colony, conducted and acquired dat

MAS maintained the cattle tick colony, conducted and acquired data from the stall test, and supported laboratory experiments involving the purification of rRmLTI. FDG assisted with the bioinformatics analysis and interpretation of data related to the BmTI EST sequence, and article preparation. FPLL contributed to check details study design for polyclonal antibody production, murine serum sample collection, and immune response

analysis. AAPL co-developed proposal funded to test the immunoprotection of trypsin inhibitors from cattle tick larvae, analyzed and interpreted the data, and drafted the article. All authors approved the final version of the manuscript submitted for publication. “
“Infection with wild-type influenza induces immunity to subsequent infection with antigenically related strains primarily through serum

and mucosal antibodies. While serum antibodies are generally responsible for lower respiratory tract protection, local mucosal antibodies are critical for protection of the upper respiratory tract. T-cell and innate immune responses also contribute to protection and reductions in illness severity [1], [2] and [3]. In order to prevent influenza illness, vaccination has long been established as the preferred approach [4]. An Ann Arbor strain live attenuated influenza vaccine (LAIV; MedImmune, LLC, Gaithersburg, MD) is licensed for use in a number of countries in eligible individuals 2–49 years of age [5]; in the European Alectinib Union, LAIV is approved

for use in children 2–17 years of age; in Canada, LAIV all is approved for individuals 2–59 years of age. LAIV has been shown to be effective in preventing culture-confirmed influenza illness in children and adults [6], [7] and [8]; in children, studies have demonstrated that LAIV provides greater protection than standard inactivated influenza vaccines [9], [10], [11] and [12]. However, despite multiple immunologic investigations, robust immunologic correlates of protection have not been established for LAIV. Although functional serum antibody titers as measured by hemagglutination inhibition (HAI) are generally regarded as the correlate of protection for inactivated influenza vaccines, the general trend observed in studies of LAIV-induced immune responses is that adults demonstrate limited serum antibody responses to LAIV; by comparison, young children, particularly those without pre-existing antibodies, can exhibit higher rates of seroconversion in response to vaccination [13], [14], [15], [16], [17], [18], [19], [20] and [21]. Studies have demonstrated that LAIV can induce protective immunity in the absence of robust serum antibody responses [22], [23], [24] and [25]. Studies have also demonstrated that LAIV induces mucosal antibody responses [26] and [27] and T-cell responses [17], [28], [29] and [30] that may contribute to protective immunity.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>